Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoids: potential anticancer agents.

Manuel Guzmán1

  • 1Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, 28040 Madrid, Spain. mgp@bbm1.ucm.es

Nature Reviews. Cancer
|October 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabinoid CB<sub>2</sub> receptor drives trastuzumab resistance and predicts durable anti-HER2 response.

Oncogene·2026
Same author

Cannabinoid CB<sub>1</sub> receptors drive oligodendrocyte maturation during myelin regeneration.

Cell communication and signaling : CCS·2026
Same author

PCMT1 generates the C-terminal cyclic imide degron on CRBN substrates.

Nature chemical biology·2025
Same author

Prenatal Downregulation of CB<sub>1</sub> Cannabinoid Receptors in the Mouse Prefrontal Cortex Disrupts Cortical Lamination and Induces a Transcriptional Signature Associated with Social Interaction Deficits.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models.

Translational neurodegeneration·2025
Same author

PCMT1 generates the C-terminal cyclic imide degron on CRBN substrates.

bioRxiv : the preprint server for biology·2025
Same journal

Escaping the trap.

Nature reviews. Cancer·2026
Same journal

A genomic and epigenomic lens into the biology of acute lymphoblastic leukaemia.

Nature reviews. Cancer·2026
Same journal

Systemic health impact of cancer-associated extracellular vesicles and particles.

Nature reviews. Cancer·2026
Same journal

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026
Same journal

CLIM-TIME links tumour genetics to spatial immune architecture.

Nature reviews. Cancer·2026
Same journal

Serving sulfur to boost anti-tumour immunity.

Nature reviews. Cancer·2026
See all related articles

Cannabinoids, active compounds from Cannabis sativa, offer palliative care for cancer patients by managing symptoms and may inhibit tumor growth. Further research could explore their potential as novel anticancer therapies due to their favorable safety profile compared to chemotherapy.

Area of Science:

  • Oncology
  • Pharmacology
  • Cannabinoid Science

Background:

  • Cannabinoids are active compounds derived from Cannabis sativa.
  • They are known for palliative effects in cancer care, including antiemesis, analgesia, and appetite stimulation.
  • Existing research suggests cannabinoids can inhibit tumor cell growth in vitro and in vivo.

Purpose of the Study:

  • To explore the potential of cannabinoids as a novel therapeutic strategy for cancer treatment.
  • To evaluate the anticancer effects of cannabinoids beyond their palliative applications.
  • To assess the feasibility of developing cannabinoid-based anticancer therapies.

Main Methods:

  • Review of existing literature on cannabinoid pharmacology and oncology.
  • Analysis of preclinical studies (cell culture and animal models) investigating cannabinoid anti-tumor activity.

Related Experiment Videos

  • Evaluation of safety and tolerability data of cannabinoids in cancer patients.

    • Main Results:

    • Cannabinoids demonstrate significant palliative benefits for cancer patients, alleviating nausea, vomiting, pain, and increasing appetite.
    • Preclinical evidence indicates that cannabinoids can modulate key cell-signalling pathways to inhibit tumor cell proliferation and induce apoptosis.
    • Cannabinoids are generally well-tolerated and lack the severe systemic toxicity associated with conventional chemotherapeutic agents.

    Conclusions:

    • Cannabinoids possess both palliative and potentially direct anti-tumor properties.
    • Their favorable safety profile makes them attractive candidates for developing new anticancer treatments.
    • Further clinical investigation is warranted to establish the efficacy of cannabinoids as a standalone or adjunct cancer therapy.